NRX Pharmaceuticals (NRXP) Research & Development (2020 - 2026)
NRX Pharmaceuticals (NRXP) reported Research & Development of $2.12 million for Q2 2026, up 114.4% from $987,000 a year earlier and up 61.7% from the prior quarter.
Powered by 
Analysis
NRX Pharmaceuticals (NRXP) Research & Development (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, NRX Pharmaceuticals' Research & Development came in at $5.41 million, up 57.4% year-over-year; for FY2025, it came in at $3.78 million, down 39.1% from FY2024.
- Research & Development has declined for four consecutive years, with a five-year compound annual growth rate of -18.7% (FY2020 to FY2025).
- By year, Research & Development came in at $6.2 million in FY2024 (-53.6%), $13.37 million in FY2023 (-21.5%), $17.03 million in FY2022 (-15.9%) and $20.26 million in FY2021 (+90.7%).
- The Q2 2026 figure ranks as the highest quarterly Research & Development since Q2 2024.
- Year over year, Research & Development gained in three of the last eight quarters, with growth averaging 0.7%.
- The high point for year-over-year Research & Development in five years was Q3 2025 (growth of 133.9%); the low point was Q1 2023 (a decline of 85.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.31 million (Q1 2026), $558,000 (Q4 2025) and $1.43 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 2.81 Bn |
| 10 | NRX Pharmaceuticals | 103.58 Mn | 55.17 Mn | 426,000.00 | 2.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.12 Mn |
| Mar 31, 2026 | 1.31 Mn |
| Dec 31, 2025 | 558,000.00 |
| Sep 30, 2025 | 1.43 Mn |
| Jun 30, 2025 | 987,000.00 |
| Mar 31, 2025 | 804,000.00 |
| Dec 31, 2024 | 1.04 Mn |
| Sep 30, 2024 | 611,000.00 |
| Jun 30, 2024 | 2.80 Mn |
| Mar 31, 2024 | 1.75 Mn |
| Dec 31, 2023 | 2.53 Mn |
| Sep 30, 2023 | 3.31 Mn |
| Jun 30, 2023 | 3.87 Mn |
| Mar 31, 2023 | 804,000.00 |
| Dec 31, 2022 | 4.46 Mn |
| Sep 30, 2022 | 4.13 Mn |
| Jun 30, 2022 | 2.96 Mn |
| Mar 31, 2022 | 5.48 Mn |
| Dec 31, 2021 | 6.41 Mn |
| Sep 30, 2021 | 6.28 Mn |
API Access
NRX Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=NRXP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "NRXP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=NRXP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();